C151H286N16O11 — CID 157166317
5-tert-butyl-3-(methoxymethyl)-1H-indole;4-tert-butyl-N-methyl-N-[2-[(2-methylpropan-2-yl)oxy]ethyl]cyclohexan-1-amine;1-tert-butyl-4-[[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidin-3-yl]methyl]piperazine;1-tert-butyl-4-[2-[2-[(2-methylpropan-2-yl)oxymethyl]cyclopropyl]ethyl]piperazine;1-tert-butyl-4-[[4-[(2-methylpropan-2-yl)oxymethyl]piperidin-1-yl]methyl]piperidine;3-(2,2-dimethylpropyl)-1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidine;1-(2,2-dimethylpropyl)-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;2-ethyl-5-[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidin-3-yl]oxypyrazine;5-ethyl-2-[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidin-3-yl]oxypyridine (PubChem CID 157166317) has the molecular formula C151H286N16O11 and a molecular weight of 2502.05 g/mol. Its IUPAC name is 5-tert-butyl-3-(methoxymethyl)-1H-indole;4-tert-butyl-N-methyl-N-[2-[(2-methylpropan-2-yl)oxy]ethyl]cyclohexan-1-amine;1-tert-butyl-4-[[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidin-3-yl]methyl]piperazine;1-tert-butyl-4-[2-[2-[(2-methylpropan-2-yl)oxymethyl]cyclopropyl]ethyl]piperazine;1-tert-butyl-4-[[4-[(2-methylpropan-2-yl)oxymethyl]piperidin-1-yl]methyl]piperidine;3-(2,2-dimethylpropyl)-1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidine;1-(2,2-dimethylpropyl)-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;2-ethyl-5-[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidin-3-yl]oxypyrazine;5-ethyl-2-[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidin-3-yl]oxypyridine.
| Compound Name | 5-tert-butyl-3-(methoxymethyl)-1H-indole;4-tert-butyl-N-methyl-N-[2-[(2-methylpropan-2-yl)oxy]ethyl]cyclohexan-1-amine;1-tert-butyl-4-[[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidin-3-yl]methyl]piperazine;1-tert-butyl-4-[2-[2-[(2-methylpropan-2-yl)oxymethyl]cyclopropyl]ethyl]piperazine;1-tert-butyl-4-[[4-[(2-methylpropan-2-yl)oxymethyl]piperidin-1-yl]methyl]piperidine;3-(2,2-dimethylpropyl)-1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidine;1-(2,2-dimethylpropyl)-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;2-ethyl-5-[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidin-3-yl]oxypyrazine;5-ethyl-2-[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidin-3-yl]oxypyridine |
|---|---|
| PubChem CID | 157166317 |
| Molecular Formula | C151H286N16O11 |
| Molecular Weight | 2502.05 g/mol |
| Exact Mass | 2500.23 |
| IUPAC Name | 5-tert-butyl-3-(methoxymethyl)-1H-indole;4-tert-butyl-N-methyl-N-[2-[(2-methylpropan-2-yl)oxy]ethyl]cyclohexan-1-amine;1-tert-butyl-4-[[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidin-3-yl]methyl]piperazine;1-tert-butyl-4-[2-[2-[(2-methylpropan-2-yl)oxymethyl]cyclopropyl]ethyl]piperazine;1-tert-butyl-4-[[4-[(2-methylpropan-2-yl)oxymethyl]piperidin-1-yl]methyl]piperidine;3-(2,2-dimethylpropyl)-1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidine;1-(2,2-dimethylpropyl)-4-[(2-methylpropan-2-yl)oxymethyl]piperidine;2-ethyl-5-[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidin-3-yl]oxypyrazine;5-ethyl-2-[1-[2-[(2-methylpropan-2-yl)oxy]ethyl]pyrrolidin-3-yl]oxypyridine |
| SMILES | CC(C)(C)CC1CCN(CCOC(C)(C)C)C1.CC(C)(C)CN1CCC(COC(C)(C)C)CC1.CC(C)(C)OCC1CC1CCN1CCN(C(C)(C)C)CC1.CC(C)(C)OCC1CCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)OCCN1CCC(CN2CCN(C(C)(C)C)CC2)C1.CCc1ccc(OC2CCN(CCOC(C)(C)C)C2)nc1.CCc1cnc(OC2CCN(CCOC(C)(C)C)C2)cn1.CN(CCOC(C)(C)C)C1CCC(C(C)(C)C)CC1.COCc1c[nH]c2ccc(C(C)(C)C)cc12 |
| InChI | InChI=1S/C20H40N2O.C19H39N3O.C18H36N2O.C17H28N2O2.C17H35NO.C16H27N3O2.2C15H31NO.C14H19NO/c1-19(2,3)22-13-9-17(10-14-22)15-21-11-7-18(8-12-21)16-23-20(4,5)6;1-18(2,3)22-11-9-21(10-12-22)16-17-7-8-20(15-17)13-14-23-19(4,5)6;1-17(2,3)20-11-9-19(10-12-20)8-7-15-13-16(15)14-21-18(4,5)6;1-5-14-6-7-16(18-12-14)21-15-8-9-19(13-15)10-11-20-17(2,3)4;1-16(2,3)14-8-10-15(11-9-14)18(7)12-13-19-17(4,5)6;1-5-13-10-18-15(11-17-13)21-14-6-7-19(12-14)8-9-20-16(2,3)4;1-14(2,3)12-16-9-7-13(8-10-16)11-17-15(4,5)6;1-14(2,3)11-13-7-8-16(12-13)9-10-17-15(4,5)6;1-14(2,3)11-5-6-13-12(7-11)10(8-15-13)9-16-4/h17-18H,7-16H2,1-6H3;17H,7-16H2,1-6H3;15-16H,7-14H2,1-6H3;6-7,12,15H,5,8-11,13H2,1-4H3;14-15H,8-13H2,1-7H3;10-11,14H,5-9,12H2,1-4H3;2*13H,7-12H2,1-6H3;5-8,15H,9H2,1-4H3 |
| InChIKey | AMYKOVXZOBDOFI-UHFFFAOYSA-N |
| XLogP | 30.10 |
| TPSA | 194.87 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 26 |
| Rotatable Bonds | 39 |
| Heavy Atoms | 178 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2502.05 |
| LogP ≤ 5 | 30.10 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 26 |